The Silver Tsunami will see an unprecedented number of seniors in Canada. Thanks to a $3-million investment from The Slaight Family Foundation, University Health Network (UHN) is one step closer to being able to design programs and supports to enable seniors to live and thrive in their communities.
More than 1,900 participants, making up 167 teams, faced off today at Woodbine Racetrack in Toronto and raised a record-breaking $3.1 million as part of the 9th annual Scotiabank Road Hockey to Conquer Cancer. This brings the annual event’s nine-year fundraising total to over $23 million raised.
Canada’s largest-ever concussion study, led by researchers at Toronto Rehab, has uncovered rates that are nearly double what has previously been recorded, showcasing the need for increased education about concussion and access to more specialized, best-in-practice concussion care.
With a $10-million donation, the University of Toronto is partnering with Princess Margaret Cancer Centre to launch the McCain Centre for Urological Innovation and Education.
A first of its kind study is reporting that millions of women in low- and middle-income countries will need life-saving radiotherapy to treat their cervical cancer, despite the growth of essential human papilloma virus (HPV) vaccination prevention programs.
An anonymous living liver donor helped the UHN Transplant Program achieve a North American first with an innovative living liver donor exchange, or “swap,” that saved the lives of two failing liver patients, with the potential to save many more.
New research from the laboratory of cancer scientist Dr. Tak Mak, renowned for cloning the human T-cell receptor, has demonstrated that immune cells make brain chemicals to fight off infections.
Dr. Bradly Wouters, Executive Vice President, Science and Research – University Health Network (UHN) announced today the appointment of Aaron Schimmer MD, PhD, FRCPC to the position of Research Director at Princess Margaret Cancer Centre, UHN.
A clinical-scientific team specializing in head-and-neck cancer has identified a way to manipulate metabolism to potentially curb skin fibrosis - a common side effect of radiotherapy affecting quality of life of cancer survivors.
Scientists at the Peter Munk Cardiac Centre, at the University Health Network, have identified the type of cell key to helping the heart repair and potentially regenerate following a heart attack.
Patients who experience disturbances in sleep, mobility, nutrition or mood while admitted in hospital may be more likely to be readmitted within 30 days after discharge, finds a new study co-led by St. Michael’s Hospital and the University Health Network (UHN) in Canada.
Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined “liquid biopsy”, epigenetic alterations and machine learning to develop a blood test to detect and classify cancer at its earliest stages.
Scientists led by Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have discovered a gene signature biomarker that may predict which patients will respond – or not – to immune therapy.
A new study out of the Krembil Brain Institute, part of the Krembil Research Institute, suggests drinking coffee may protect you against developing both Alzheimer’s and Parkinson’s disease.
A map of the cells in the human liver has been created by University Health Network Transplant Program and University of Toronto researchers, revealing for the first time differences between individual cells at the molecular level which can have a profound impact on their behaviour in tissue, tumours and disease.
Declared “Officially Amazing” by Guinness World Record adjudicator Michael Empric last year, Rocket Ride for Rehab is returning to Nathan Phillips Square this Saturday, October 13th in support of Toronto Rehab Foundation.
A research team at the Krembil Research Institute in Toronto has developed an innovative strategy that could help to restore breathing following traumatic spinal cord injury.
Scientists at the Krembil Research Institute have developed a novel therapeutic treatment that has the potential to stop knee and spine osteoarthritis in its tracks.
Media are invited to attend The Princess Margaret Cancer Foundation’s (PMCF) annual launch of their BREASTOBER program.
On September 29th, hockey legends, media personalities and passionate players will unite at the 8th annual Scotiabank Road Hockey to Conquer Cancer to defeat their toughest opponent yet.
In a remarkable new genetic discovery, researchers at the Peter Munk Cardiac Centre, University Health Network (UHN), Ted Rogers Centre for Heart Research and The Hospital for Sick Children (SickKids) have found strong evidence that rare DNA variations can lead to Tetralogy of Fallot (ToF).
An Ontario clinical study that shows adding PET imaging to conventional CT imaging to stage locally advanced cervix cancer can change treatment means newly diagnosed women in this province may also receive PET imaging.
The Princess Margaret Cancer Foundation announced today that Meaghan Stovel McKnight has been appointed Chief Operating Officer, a new position within the Foundation.
A study led by researchers at the Peter Munk Cardiac Centre (PMCC) at UHN suggests that the model used by the Canadian Institute for Health Information (CIHI) significantly underestimates mortality in specialized heart surgery centres. The findings show that CIHI's model does not capture all of the medical problems that patients at high risk for surgery have.
The role of insulin as a boost to the immune system to improve its ability to fight infection has been detailed for the first time by Toronto General Hospital Research Institute (TGHRI) scientists.
A unique pain program is helping complex surgical patients wean off opioids safely and effectively, while offering alternative ways to cope with their pain and improve how they function.
An international team of leukemia scientists has discovered how to predict healthy individuals at risk of developing acute myeloid leukemia (AML), an aggressive and often deadly blood cancer.
A new study published in Circulation, a peer-reviewed journal of the American Heart Association and led by a cardiologist at the Peter Munk Cardiac Centre at Toronto General Hospital has found evidence that only one of the 21 genes normally associated with Brugada Syndrome is a definitive cause of the condition.
An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix (DBS-f), as observed in the data from the phase 2 findings (12 – 24 months) of the Phase II trial.
Donor lungs from individuals infected with hepatitis C have been successfully transplanted into 10 patients at Toronto General Hospital (TG), University Health Network (UHN).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right